These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3262991)

  • 21. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WEB 2086, a novel specific PAF antagonist, prevents PAF induced arrhythmogenicity.
    Mest HJ; Riedel A; Rein T
    Pharmacol Res; 1990; 22(4):445-53. PubMed ID: 2402478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.
    Detsouli A; Lefort J; Vargaftig BB
    Br J Pharmacol; 1985 Apr; 84(4):801-10. PubMed ID: 4005486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
    Berti F; Omini C; Rossoni G; Braquet P
    Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection.
    Desquand S; Lefort J; Dumarey C; Vargaftig BB
    Br J Pharmacol; 1991 Mar; 102(3):687-95. PubMed ID: 1285397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ibudilast, a novel antiasthmatic agent, on anaphylactic bronchoconstriction: predominant involvement of endogenous slow reacting substance of anaphylaxis.
    Ohashi M; Uno T; Nishino K
    Int Arch Allergy Immunol; 1993; 101(3):288-96. PubMed ID: 8324390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts.
    Vleeming W; Wemer J; Porsius AJ
    J Cardiovasc Pharmacol; 1992; 20(5):790-9. PubMed ID: 1280743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the lipoxygenase inhibitor N-hydroxy-N-(6-methoxy-3,4-dihydro-2-naphthylmethyl)urea on bronchoconstriction and lung vascular permeability in anaphylactic guinea pigs.
    Geist C; Schneider J; Zimmer O
    Arzneimittelforschung; 1995 Feb; 45(2):155-8. PubMed ID: 7710438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.
    Vilain B; Lagente V; Touvay C; Desquand S; Randon J; Lefort J; Braquet P; Vargaftig BB
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():119-26. PubMed ID: 3774840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
    Sakamoto T; Elwood W; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
    Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K
    Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of the selective PAF antagonist WEB 2170 on PAF and antigen induced airway hyperresponsiveness and eosinophil infiltration.
    Seeds EA; Coyle AJ; Page CP
    J Lipid Mediat; 1991; 4(1):111-21. PubMed ID: 1893085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs.
    Lagente V; Boichot E; Carre C; Guinot P; Mencia-Huerta JM; Braquet P
    Clin Exp Allergy; 1993 Dec; 23(12):1002-10. PubMed ID: 10779293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchopulmonary responses to endothelin-1 in sensitized and challenged guinea-pigs: role of cyclooxygenase metabolites and platelet-activating factor.
    Boichot E; Lagente V; Mencia-Huerta JM; Braquet P
    Fundam Clin Pharmacol; 1993; 7(6):281-91. PubMed ID: 8406292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.